InnoPharmax Inc. announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was TWD 84.891 million compared to TWD 56.490 million a year ago. Operating loss was TWD 74.948 million compared to TWD 80.249 million a year ago. Net loss was TWD 87.893 million compared to TWD 86.348 million a year ago. Basic loss per share was TWD 1.24 compared to TWD 1.23 a year ago.